Evidence map›Paper›PMID 40560443›Full record

SynthesisWorld journal of urology2025

Global prevalence and etiologies of urinary tract infection among oncologic patients: a systematic review and meta-analysis.

Muluneh Assefa, Mitkie Tigabie, Azanaw Amare, Abebe Birhanu, Wesam Taher Almagharbeh, Getu Girmay

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muluneh AssefaDepartment of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar, Ethiopia. mulunehassefa2010@gmail.com.
Mitkie TigabieDepartment of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar, Ethiopia.
Azanaw AmareDepartment of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar, Ethiopia.
Abebe BirhanuDepartment of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar, Ethiopia.
Wesam Taher AlmagharbehDepartment of Medical and Surgical Nursing, Faculty of Nursing, University of Tabuk, Tabuk, Saudi Arabia.
Getu GirmayDepartment of Immunology and Molecular Biology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChemotherapy can lead to severe and prolonged immunosuppression, which puts oncologic patients at a higher risk of UTIs. This review determined the global prevalence and etiologic agents of UTIs among oncologic patients.

methodsThe Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used for reporting. The article search was performed via PubMed, Medline, EMBASE, Google Scholar, Hinari, Web of Science, Science Direct, and African Journals Online. Data were extracted via a Microsoft Excel spreadsheet and analyzed via STATA version 11.0. A random effects model was used to estimate the pooled effect size across the studies. The heterogeneity was checked via the I

resultsEighteen articles were eligible for this review. The pooled estimate of UTI incidence was 34.39% (95% CI: 22.29-46.49), with high heterogeneity (I

conclusionThere is a significant global burden of UTIs (34.39%) in oncologic patients. This requires regular screening of UTIs in oncologic patients to minimize further complications, better monitoring, and early treatment.

Indexed as

NeoplasmsUrinary Tract InfectionsGlobal HealthHumansPrevalenceEtiologiesMeta-analysisOncologic patientsSystematic reviewUrinary tract infection

Identifiers

PMID40560443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.